Tanespimycin (T) + Bortezomib (BZ) in Multiple Myeloma (MM): Confirmation of the Recommended Dose Using a Novel Formulation von Richardson, Paul G., Chanan-Khan, Asher, Lonial, Sagar, Krishman, Amrita, Carroll, Michael, Cropp, G.F., Kersey, K., Abitar, M., Johnson, R.G., Hannah, Alison L., Anderson, Kenneth C.

Volltext

638 POSTER Phase 1 trial of a novel epothilone, KOS-1584, using a weekly dosing schedule von Burris, H., Stopeck, A., Thomas, E., Jones, S., Cohen, J., Dice, K., Dampier, B., Cropp, G.F., Zhong, Z., Hannah, A.L.

Volltext